CN106133146B - 重组糖蛋白生产中的细胞生长和糖基化的调节 - Google Patents

重组糖蛋白生产中的细胞生长和糖基化的调节 Download PDF

Info

Publication number
CN106133146B
CN106133146B CN201580010823.5A CN201580010823A CN106133146B CN 106133146 B CN106133146 B CN 106133146B CN 201580010823 A CN201580010823 A CN 201580010823A CN 106133146 B CN106133146 B CN 106133146B
Authority
CN
China
Prior art keywords
copper
manganese
zinc
iron
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580010823.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN106133146A (zh
Inventor
O·波普
N·博康
G·德拉内尔
S·埃斯林格尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN106133146(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN106133146A publication Critical patent/CN106133146A/zh
Application granted granted Critical
Publication of CN106133146B publication Critical patent/CN106133146B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN201580010823.5A 2014-02-27 2015-02-24 重组糖蛋白生产中的细胞生长和糖基化的调节 Active CN106133146B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14157030.9 2014-02-27
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (2)

Publication Number Publication Date
CN106133146A CN106133146A (zh) 2016-11-16
CN106133146B true CN106133146B (zh) 2021-05-04

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580010823.5A Active CN106133146B (zh) 2014-02-27 2015-02-24 重组糖蛋白生产中的细胞生长和糖基化的调节

Country Status (20)

Country Link
US (3) US20170058309A1 (https=)
EP (1) EP3110961B1 (https=)
JP (2) JP6831702B2 (https=)
KR (1) KR102280638B1 (https=)
CN (1) CN106133146B (https=)
BR (1) BR112016017660B1 (https=)
CA (1) CA2937611C (https=)
DK (1) DK3110961T3 (https=)
ES (1) ES2769003T3 (https=)
HR (1) HRP20200100T1 (https=)
HU (1) HUE047575T2 (https=)
LT (1) LT3110961T (https=)
MX (1) MX369395B (https=)
PL (1) PL3110961T3 (https=)
PT (1) PT3110961T (https=)
RS (1) RS59881B1 (https=)
RU (1) RU2712562C2 (https=)
SG (1) SG11201606856SA (https=)
SI (1) SI3110961T1 (https=)
WO (1) WO2015128314A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012340849B2 (en) 2011-11-21 2017-11-02 Innovation Hammer Llc Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same
BR112016017660B1 (pt) * 2014-02-27 2022-04-19 F. Hoffmann-La Roche Ag Método para a produção de uma glicoproteína recombinante
CA2969225C (en) 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
BR112018072235B1 (pt) 2016-04-29 2023-01-17 Innovation Hammer Llc Método para intensificar o crescimento respiratório de um organismo fotossintético que compreende aplicar uma formulação de compósito de glicano
CA3056011A1 (en) 2017-03-14 2018-09-20 Amgen Inc. Control of total afucosylated glycoforms of antibodies produced in cell culture
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
MX2020009605A (es) * 2018-03-16 2021-01-08 Genzyme Corp Metodos para mejorar la viabilidad celular en un biorreactor de produccion.
US12325737B2 (en) * 2018-03-26 2025-06-10 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
AU2019274782A1 (en) * 2018-05-24 2020-12-03 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
EA202191352A1 (ru) * 2018-11-13 2021-08-11 Янссен Байотек, Инк. Контроль содержания микроэлементов-металлов во время продукции антител к cd38
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法
US20230265204A1 (en) * 2020-04-24 2023-08-24 Hoffmann-La Roche Inc. Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
CN121712803A (zh) * 2023-08-16 2026-03-20 葛兰素史密斯克莱知识产权有限公司 控制抗体糖基化谱的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
WO2011095596A1 (en) * 2010-02-04 2011-08-11 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
AU4330597A (en) 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
DE69929198T2 (de) * 1998-05-29 2006-08-10 Genentech, Inc., South San Francisco Zellkulturverfahren für die produktion von glycoproteinen
JP2001120262A (ja) * 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
EP1360314B1 (en) 2001-02-15 2009-01-14 Centocor, Inc. Chemically defined medium for cultured mammalian cells
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
ES2361559T3 (es) 2004-11-02 2011-06-20 Ares Trading S.A. Medio de cultivo de células exento de suero para mamíferos.
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
EP2495308A1 (en) * 2005-12-08 2012-09-05 Amgen Inc. Improved production of glycoproteins using manganese
EP3255141B1 (en) * 2006-07-13 2021-12-01 Wyeth LLC Production of antibodies with improved glycosylation pattern
ES2541546T3 (es) 2006-11-03 2015-07-21 Wyeth Llc Sustancias que inhiben la glucólisis en cultivo celular
AU2008223133A1 (en) 2007-03-02 2008-09-12 Wyeth Use of copper and glutamate in cell culture for production of polypeptides
US20110053223A1 (en) * 2009-08-14 2011-03-03 Robert Bayer Cell culture methods to make antibodies with enhanced adcc function
PL2563906T3 (pl) 2010-04-26 2018-04-30 Novartis Ag Sposób hodowli komórek cho
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CN105189735B (zh) 2011-04-29 2019-04-12 拜康研究有限公司 在培养期间减少乳酸累积的方法和生产多肽的方法
EP2809773B1 (en) * 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
BR112016017660B1 (pt) * 2014-02-27 2022-04-19 F. Hoffmann-La Roche Ag Método para a produção de uma glicoproteína recombinante

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
WO2011095596A1 (en) * 2010-02-04 2011-08-11 Vivalis Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Effect of the manganese ion on human α3/4 fucosyltransferase III activity;Angelina S. Palma等;《BioMetals》;20030630;第17卷;35-43 *

Also Published As

Publication number Publication date
SG11201606856SA (en) 2016-09-29
LT3110961T (lt) 2020-02-10
MX2016010236A (es) 2016-10-13
HUE047575T2 (hu) 2020-04-28
RS59881B1 (sr) 2020-03-31
PT3110961T (pt) 2020-01-29
RU2016138176A3 (https=) 2018-10-29
KR20160125514A (ko) 2016-10-31
WO2015128314A1 (en) 2015-09-03
MX369395B (es) 2019-11-07
PL3110961T3 (pl) 2020-04-30
JP2020054351A (ja) 2020-04-09
US20210222220A1 (en) 2021-07-22
US20240327890A1 (en) 2024-10-03
RU2712562C2 (ru) 2020-01-29
RU2016138176A (ru) 2018-03-29
US20170058309A1 (en) 2017-03-02
ES2769003T3 (es) 2020-06-24
JP2017506515A (ja) 2017-03-09
CA2937611C (en) 2023-01-03
BR112016017660B1 (pt) 2022-04-19
DK3110961T3 (da) 2020-02-03
HRP20200100T1 (hr) 2020-04-03
CN106133146A (zh) 2016-11-16
SI3110961T1 (sl) 2020-03-31
JP6934507B2 (ja) 2021-09-15
CA2937611A1 (en) 2015-09-03
KR102280638B1 (ko) 2021-07-22
BR112016017660A2 (https=) 2017-08-08
EP3110961B1 (en) 2019-11-27
JP6831702B2 (ja) 2021-02-17
EP3110961A1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
CN106133146B (zh) 重组糖蛋白生产中的细胞生长和糖基化的调节
US20250382568A1 (en) Use of perfusion seed cultures to improve biopharmaceutical fedbatch production capacity and product quality
EP3036320B1 (en) Control of protein glycosylation by culture medium supplementation and cell culture process parameters
JP6971221B2 (ja) 組換えタンパク質のガラクトース含有量を増加させる方法
KR102894782B1 (ko) 세포 배양에서 생산된 재조합 당단백질의 글리코실화 프로파일의 변형 방법
JP7551760B2 (ja) 哺乳動物細胞培養プロセス
CN109072273B (zh) 使用全乙酰基半乳糖调节重组蛋白的蛋白质半乳糖基化概况的方法
JP2026034442A (ja) スペソリマブを産生するための方法
HK1231927A1 (en) Modulation of cell growth and glycosylation in recombinant glycoprotein production
HK1231927B (zh) 重组糖蛋白生产中的细胞生长和糖基化的调节
CA3118604C (en) Method for modifying the glycosylation profile of a recombinant glycoprotein produced in cell culture
EA049171B1 (ru) Способ производства спесолимаба

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1231927

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant